Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
text
Tags
biotech
life sciences
national blog main
boston blog main
clinical trials
fda
indiana blog main
indiana top stories
amgen
boston top stories
eli lilly
national top stories
raleigh-durham blog main
raleigh-durham top stories
teva pharmaceutical
boulder/denver blog main
boulder/denver top stories
calcitonin gene-related peptide
chronic migraine
detroit blog main
detroit top stories
migraine research foundation
new york blog main
new york top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
drugs
episodic migraine
eptinezumab
erenumab
fremanezumab
galcanezumab
What
approval
8
×
won
8
×
fda
drug
new
migraine
class
developed
announced
approved
decades
eli
friday
late
lilly
medicines
oral
pain
second
starts
therapeutics
therapy
acute
addresses
agency
aimmune
alex
allergy
amgen
app
arguments
awarded
based
betting
big
billion
biopharma
bitcoin
blockchain
candidates
Language
unset
Current search:
won
×
approval
×
@wired.com
2 years ago
Google Launches a New Medical App—Outside the US
@xconomy.com
4 years ago
Aimmune Awarded First FDA Approval for a Peanut Allergy Therapy
@xconomy.com
4 years ago
Roche Puts Up Historic $1.15B for Sarepta Duchenne Gene Therapy Deal
@xconomy.com
4 years ago
FDA OKs Lilly’s Lasmiditan, First New Acute Migraine Drug in Decades
@xconomy.com
4 years ago
At Big Neuro Meeting, Migraine Drug Competitors to Make Oral Arguments
@xconomy.com
5 years ago
Eli Lilly Migraine Drug Approved, the Third in New Class of Medicines
@xconomy.com
5 years ago
Amgen Migraine Drug Gets FDA Nod, First in New Class of Medicines
@cryptocoinsnews.com
8 years ago
Overstock Blockchain Securities Platform Presses Onward, with Some Questions Raised